Advertisement
Loading...

TerrAscend Corp.

TRSSFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.72
$-0.23(-11.79%)
U.S. Market is Open • 14:56
Advertisement

TerrAscend Corp. Fundamental Analysis

TerrAscend Corp. (TRSSF) shows weak financial fundamentals with a PE ratio of -7.00, profit margin of -29.70%, and ROE of -75.05%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.10
Current Ratio1.51

Areas of Concern

ROE-75.05%
We analyze TRSSF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -93.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-93.6/100

We analyze TRSSF's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRSSF struggles to generate sufficient returns from assets.

ROA > 10%
-13.80%

Valuation Score

Excellent

TRSSF trades at attractive valuation levels.

PE < 25
-7.00
PEG Ratio < 2
-0.10

Growth Score

Weak

TRSSF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TRSSF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.53
Current Ratio > 1
1.51

Profitability Score

Weak

TRSSF struggles to sustain strong margins.

ROE > 15%
-7504.58%
Net Margin ≥ 15%
-29.70%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRSSF Expensive or Cheap?

P/E Ratio

TRSSF trades at -7.00 times earnings. This suggests potential undervaluation.

-7.00

PEG Ratio

When adjusting for growth, TRSSF's PEG of -0.10 indicates potential undervaluation.

-0.10

Price to Book

The market values TerrAscend Corp. at 5.84 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.84

EV/EBITDA

Enterprise value stands at 30.66 times EBITDA. This signals the market has high growth expectations.

30.66

How Well Does TRSSF Make Money?

Net Profit Margin

For every $100 in sales, TerrAscend Corp. keeps $-29.70 as profit after all expenses.

-29.70%

Operating Margin

Core operations generate 17.59 in profit for every $100 in revenue, before interest and taxes.

17.59%

ROE

Management delivers $-75.05 in profit for every $100 of shareholder equity.

-75.05%

ROA

TerrAscend Corp. generates $-13.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-13.80%

Following the Money - Real Cash Generation

Operating Cash Flow

TerrAscend Corp. produces operating cash flow of $39.22M, showing steady but balanced cash generation.

$39.22M

Free Cash Flow

TerrAscend Corp. generates strong free cash flow of $39.22M, providing ample flexibility for dividends, buybacks, or growth.

$39.22M

FCF Per Share

Each share generates $0.11 in free cash annually.

$0.11

FCF Yield

TRSSF converts 5.74% of its market value into free cash.

5.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.10

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.84

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.36

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.53

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.51

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.75

vs 25 benchmark

ROA

Return on assets percentage

-0.14

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How TRSSF Stacks Against Its Sector Peers

MetricTRSSF ValueSector AveragePerformance
P/E Ratio-7.0029.35 Better (Cheaper)
ROE-75.05%705.00% Weak
Net Margin-29.70%-53441.00% (disorted) Weak
Debt/Equity0.530.39 Weak (High Leverage)
Current Ratio1.514.01 Neutral
ROA-13.80%-19815.00% (disorted) Weak

TRSSF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TerrAscend Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ